Suppr超能文献

一项比较腰硬联合麻醉下剖宫产术后口服镇痛与硬膜外镇痛疼痛控制效果的随机试验。

A randomized trial to compare pain control using oral analgesia with epidural analgesia after cesarean section following combined spinal-epidural anesthesia.

作者信息

Zhong T D, Liu Q, Zhao J N, Wang H W, Konstantatos A

机构信息

Department of Anesthesia, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University Institute of Clinical Medicine, Hangzhou, China.

Department of Anesthesia, Alfred Hospital, Melbourne, Victoria, Australia

出版信息

Genet Mol Res. 2014 Mar 19;13(3):7086-93. doi: 10.4238/2014.March.19.4.

Abstract

This study aimed to evaluate whether combined oral oxycodone hydrochloride-controlled release tablets plus paracetamol and tramadol hydrochloride tablets are more effective than epidural analgesia for postoperative pain control and side effects after cesarean section. We randomly enrolled 60 patients scheduled for cesarean section into either: patient-controlled epidural analgesia with 0.1% ropivacaine+0.1 μg/mL sufentanil (for postoperative 48 h)+injected pethidine on demand (E group); or controlled-release oxycodone (2x15 mg for the first postoperative 24 h; 2x10 mg for the second postoperative 24 h)+paracetamol and tramadol hydrochloride tablets (8x1 tablet for the postoperative 48 h) orally+injected pethidine on demand (O group). The E group experienced more evoked pain and uterine cramping pain at all times postoperatively. The patients who received oral analgesia had less resting pain at 6, 12, 24, and 36 h after surgery. Two patients in the E group injected pethidine (150 mg total) during the oxytocin infusion, whereas none of the O group patients injected pethidine. Pruritus was more common in the E group (P<0.05). Maternal satisfaction with the analgesia regimen was lower in the E group (P<0.01). The median duration of hospital stay was about 5 days for both groups. Postoperative pain control after cesarean section with oral oxycodone hydrochloride-controlled release tablets plus paracetamol and tramadol hydrochloride tablets is preferable to epidural analgesia, even when side effects and maternal satisfaction are taken into account.

摘要

本研究旨在评估口服盐酸羟考酮控释片联合对乙酰氨基酚及盐酸曲马多片用于剖宫产术后疼痛控制及副作用方面是否比硬膜外镇痛更有效。我们将60例计划行剖宫产的患者随机分为两组:一组采用患者自控硬膜外镇痛,药物为0.1%罗哌卡因 + 0.1 μg/mL舒芬太尼(术后48小时),按需注射哌替啶(E组);另一组口服控释羟考酮(术后第1个24小时2×15 mg;术后第2个24小时2×10 mg)+对乙酰氨基酚及盐酸曲马多片(术后48小时8×1片),按需注射哌替啶(O组)。E组在术后各时间点的诱发痛和子宫绞痛更严重。接受口服镇痛的患者在术后6、12、24和36小时静息痛较轻。E组有2例患者在输注缩宫素期间注射了哌替啶(总量150 mg),而O组无患者注射哌替啶。瘙痒在E组更常见(P<0.05)。E组产妇对镇痛方案的满意度较低(P<0.01)。两组的中位住院时间均约为5天。即使考虑到副作用和产妇满意度,剖宫产术后采用口服盐酸羟考酮控释片联合对乙酰氨基酚及盐酸曲马多片进行疼痛控制优于硬膜外镇痛。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验